Beyond Antipsychotics: Pharmacologically-Augmented Cognitive Therapies (PACTs) for Schizophrenia
نویسندگان
چکیده
منابع مشابه
The Impact of Antipsychotics on Cognitive Functioning in Schizophrenia
There is broad consensus that cognitive deficits play a crucial role for both the pathogenesis and prognosis of schizophrenic psychoses. Cognitive disturbances often precede the first psychotic episode (Cannon et al., 2000) and persist over the different stages of the illness (Goldberg et al., 1993). It is important to note, however, that not all patients display neurocognitive disturbances and...
متن کاملAntipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
BACKGROUND Although antipsychotic medication still represents the treatment of choice for schizophrenia, its objective impact on symptoms is only in the medium-effect size range and at least 50% of patients discontinue medication in the course of treatment. Hence, clinical researchers are intensively looking for complementary therapeutic options. Metacognitive training for schizophrenia patient...
متن کاملNew atypical antipsychotics for schizophrenia: iloperidone
The optimal treatment of schizophrenia poses a challenge to develop more effective treatments and safer drugs, to overcome poor compliance, discontinuation and frequent switching with available antipsychotics. Iloperidone is a new dopamine type 2/serotonin type 2A (D(2)/5-HT(2A)) antagonist structurally related to risperidone, expected to give better efficacy with less extrapyramidal symptoms t...
متن کاملSchizophrenia, antipsychotics and metabolic disease.
conceivable that there may be further claims against this or other pharmaceutical companies in respect of the metabolic consequences of antipsychotic drug treatment. We can get an understanding of the problem by starting with some clear facts. That some antipsychotic drugs can cause weight gain is undisputed; this side effect has been observed in patients receiving antipsychotic treatment since...
متن کاملA pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia.
Relationships between altered prefrontal cortical dopamine, norepinephrine, and some of the cognitive impairments of schizophrenia support an approach for pharmacological remediation of cognitive symptoms through manipulations of prefrontal cortical dopamine and norepinephrine. Atomoxetine, a selective norepinephrine reuptake inhibitor, produces a widespread increase in brain norepinephrine and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuropsychopharmacology
سال: 2011
ISSN: 0893-133X,1740-634X
DOI: 10.1038/npp.2011.195